[Current aspects of chemotherapy of ischemic heart disease].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D045930:Anabolic Agents / Q000494:pharmacology; D000700:Analgesics / Q000627:therapeutic use; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D004176:Dipyridamole / Q000494:pharmacology / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006801:Humans; D005996:Nitroglycerin / Q000494:pharmacology / Q000627:therapeutic use; D010084:Oxidation-Reduction; D010101:Oxygen Consumption; D011239:Prednisolone / Q000494:pharmacology / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D045930:Anabolic Agents; D000700:Analgesics; D014149:Tranquilizing Agents; D004176:Dipyridamole; D011239:Prednisolone; D005996:Nitroglycerin
Sovremennye aspekty farmakoterapii ishemicheskoĭ bolezni serdtsa.